Sunstein Insights
What Kind of Patent Portfolios Will Matter to Life Science Companies in the Next Five Years
"What Kind of Patent Portfolios Will Matter to Life Science Companies in the Next Five Years" has just been published by Financier Worldwide. See the lead article in 2010 Biotech and Life Sciences Sector.
Most Popular
-
FTC Ban on Non-Competes Thwarted by Texas Federal Court
-
Supreme Court Rules that Copyright Infringement Claims Can Cover Decades of Damages
-
USPTO Proposes New Rules on Terminal Disclaimers: A Potential Setback for Patentees
-
The New York Times v. OpenAI: The Biggest IP Case Ever
-
Federal Circuit Narrows “Comparison Prior Art” for Design Patent Infringement
-
Dance, Fortnite, and the “Epic” Battle for Copyright Protection
Authors
-
Steven A. Abreu
-
Robert M. Asher
-
Thomas C. Carey
-
Lawrence M. Green
-
Shane Hunter
-
Peter J. Karol
-
Eric G. J. Kaviar
-
Kelly Kutsor
-
Christopher Lacenere, Ph.D.
-
Michele Liu Baillie
-
Sunstein
-
London K. Lundstrum
-
Ian Mahany-Horton
-
Kevin R. Mosier
-
John W. Powell
-
Rob D. Pyatt
-
Jackie Salwa
-
Katherine W. Soule
-
Sharona H. Sternberg
-
Bruce D. Sunstein
-
Kerry L. Timbers
-
Lisa M. Tittemore
We use cookies to improve your site experience, distinguish you from other users and support the marketing of our services. These cookies may store your personal information. By continuing to use our website, you agree to the storing of cookies on your device. For more information, please visit our Privacy Notice.